In focus · trending topic

aHUS

12 stories · following the connections

Akari Therapeutics Announces R&D Day on April 24, 2017

By Nasdaq OMXMar 17, 2017, 11:00 AM UTC

Akari Therapeutics to Present at the 29th Annual ROTH Conference

By Nasdaq OMXMar 7, 2017, 12:00 PM UTC

Akari Therapeutics to Attend Upcoming Investor Conferences in February

By Nasdaq OMXJan 31, 2017, 12:01 PM UTC

Akari Therapeutics to Attend Upcoming Investor Conferences in February

By Nasdaq OMXJan 31, 2017, 12:01 PM UTC

Akari Therapeutics Expands Clinical and Regulatory Teams with Industry Veterans

By Nasdaq OMXJan 4, 2017, 12:00 PM UTC

Akari Therapeutics Announces FDA Allowance of IND for Clinical Development of Coversin in PNH

By Nasdaq OMXJan 3, 2017, 12:01 PM UTC

Akari Therapeutics Announces FDA Allowance of IND for Clinical Development of Coversin in PNH

By Nasdaq OMXJan 3, 2017, 12:01 PM UTC

Akari Therapeutics Announces Corporate Update with New Positive Clinical Data and a New Pipeline of Tick Derived and Engineered Proteins

By Nasdaq OMXDec 5, 2016, 12:00 PM UTC